aTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest Update

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decrease of 25.1% from the April 15th total of 399,500 shares. Based on an average trading volume of 560,900 shares, the […]

Related Keywords

Canada ,San Diego ,California ,United States ,Paul Schimmel ,Roth Mkm ,Tower Research Capital ,York Mellon Corp ,Royal Bank ,Charles Schwab Investment Management Inc ,Virtu Financial ,Nasdaq ,Atyr Pharma Inc ,Tyr Pharma ,Get Rating ,Roth Capital ,Tyr Pharma Price ,Director Paul Schimmel ,Street Group ,Schwab Investment Management ,New York Mellon Corp ,Research Capital ,Xiang Lei Yang ,Bruce Beutler ,Tyr Pharma Daily ,Atyr Pharma ,Nasdaq Life ,Life ,Medical ,53217v10 ,Stocks ,Options ,Put ,Call ,